LOVELAND, Colo., March 1, 2011 /PRNewswire/ — Heska Corporation
(Nasdaq:
HSKA; “Heska”), a leading provider of advanced diagnostic and
specialty products to veterinarians, today announced the addition
of a lactate meter analyzer to its portfolio of in-clinic blood
analyzers.
(Logo: http://photos.prnewswire.com/prnh/20000622/HESKALOGO)
Among other features, the handheld portable analyzer is used to
measure lactate, and is ideal for both in-clinic and field use. It
provides a lactate assay solution to complement the VitalPath®
and DRI-CHEM® Analyzers for complete blood analysis.
“Heska is pleased to announce another product collaboration with
Roche,” commented Michael McGinley, President and Chief Operating
Officer of Heska. “This new lactate meter analyzer will complement
Heska’s full range of blood analyzers, and is another example of
our commitment to innovation within the veterinary industry.”
About Heska
Heska Corporation (Nasdaq:
HSKA) sells advanced veterinary diagnostic and other specialty
veterinary products. Heska’s state-of-the-art offerings to its
customers include diagnostic and monitoring instruments and
supplies as well as single use, point-of-care tests, vaccines and
pharmaceuticals. The company’s core focus is on the canine and
feline markets where it strives to provide high value products and
unparalleled customer support to veterinarians. For further
information on Heska and its products, visit the company’s website
at www.heska.com.
Forward-Looking Statements
This announcement contains forward-looking statements
regarding Heska’s future financial and operating results. These
statements are base
‘/>”/>
